Pre-Market Stock News (August 28, 2007)

Douglas A. McIntyre

(ADLS) Adbvanced Life Sciences gets orphan drug designation from FDA for its metastatic melanoma indicated treatment.
(BCS) Barclays indicated down 2% pre-market on loss exposure to outside loans.

(BNI) Burlington Nothern Santa Fe stake boosted by Warren Buffett’s Berkshire Hathaway.
(COCO) Corinthian Colleges $0.04 EPS vs $0.04 est.
(HGSI) Human Genome announced it received a $40 million milestone payment related to Albuferon development from Novartis.
(MHS) Medco paying $1.5 Billion to acquired PolyMedica (PLMD) at $53 per share.
(PLMD) PolyMedica is being acquired by Medco (MHS) at $53 per share.
(SNDA) Shanda Interactive trading up 2.5% after beating earnings expectations; CFO is leaving.
(TRMB) Trimble Navigation is partnering to launch a new precision solution for farmers.
(UNH) UnitedHealth and Sierra Health Services (SIE) has received approval of their merger from Nevada’s Division of Insurance.
(VICL) Vical will begin Phase I trials of DNA vaccine against H5N1 pandemic influenza.

As you can tell, the news is getting pretty thin out there…….

Jon C. Ogg
August 28, 2007